Skip Nav Destination
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Issue Archive
January 23 2014
In this Issue
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPER
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
Rick Kapur,Iwan Kustiawan,Anne Vestrheim,Carolien A. M. Koeleman,Remco Visser,Helga K. Einarsdottir,Leendert Porcelijn,Dave Jackson,Belinda Kumpel,André M. Deelder,Dennis Blank,Björn Skogen,Mette Kjaer Killie,Terje E. Michaelsen,Masja de Haas,Theo Rispens,C. Ellen van der Schoot,Manfred Wuhrer,Gestur Vidarsson
PERSPECTIVES
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Clinical Trials & Observations
Elias Jabbour,Hagop M. Kantarjian,Giuseppe Saglio,Juan Luis Steegmann,Neil P. Shah,Concepción Boqué,Charles Chuah,Carolina Pavlovsky,Jiří Mayer,Jorge Cortes,Michele Baccarani,Dong-Wook Kim,M. Brigid Bradley-Garelik,Hesham Mohamed,Mark Wildgust,Andreas Hochhaus
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML
George S. Laszlo,Chelsea J. Gudgeon,Kimberly H. Harrington,Justine Dell’Aringa,Kathryn J. Newhall,Gary D. Means,Angus M. Sinclair,Roman Kischel,Stanley R. Frankel,Roland B. Walter
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms
Timothy Tidwell,Jeremy Wechsler,Ramesh C. Nayak,Lisa Trump,Stephen J. Salipante,Jerry C. Cheng,Jean Donadieu,Taly Glaubach,Seth J. Corey,H. Leighton Grimes,Carolyn Lutzko,Jose A. Cancelas,Marshall S. Horwitz
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
CORRESPONDENCE
The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia
Annette Hildegard Schmitt-Graeff,Philipp Erben,Juliane Schwaab,Beate Vollmer-Kary,Georgia Metzgeroth,Karl Sotlar,Hans-Peter Horny,Hans-H Kreipe,Paul Fisch,Andreas Reiter
-
Cover Image
Cover Image
The image shows the localization of Jak1 (blue) and a mutant Jak2 (green), which lacks the pseudokinase (JH2) and the kinase (JH1) domain. The Jak2 JH2-domain is necessary for maintaining the scaffold function of Jak2 and the physiological localization of Jak1 and Jak2. These results demonstrate that Jak2, independent of its kinase function, significantly shapes the subcellular localization of Jak1 highlighting the role of Jak2 as scaffold protein for the assembly of the IFN-γ receptor complex. See the article by Keil et al on page 520.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals